- •November 16, 2002
- •February 14, 2003
- •February 21
- •February 28
- •March 7
- •March 10
- •March 12
- •March 14
- •March 15
- •March 17
- •March 19
- •March 21
- •March 24
- •March 26
- •March 28
- •March 30
- •March 31
- •April 2
- •April 2
- •April 8-10
- •April 12
- •April 16
- •April 20
- •April 20
- •April 23
- •April 25
- •April 27
- •April 29
- •June 6
- •June 13
- •June 17
- •June 21
- •June 23
- •June 24
- •July 2
- •July 5
- •August 14
- •September 8
- •September 24
- •References
- •Virology
- •Discovery of the SARS Virus
- •Initial Research
- •The Breakthrough
- •Coronaviridae
- •SARS Co-V
- •Genome Sequence
- •Morphology
- •Organization
- •Detection
- •Stability and Resistance
- •Natural Host
- •Antiviral Agents and Vaccines
- •Antiviral Drugs
- •Vaccines
- •Outlook
- •References
- •Routes of Transmission
- •Factors Influencing Transmission
- •Patient Factors in Transmission
- •Asymptomatic Patients
- •Symptomatic Patients
- •Superspreaders
- •The Unsuspected Patients
- •High-Risk Activities
- •Transmission during Quarantine
- •Transmission after Recovery
- •Animal Reservoirs
- •Conclusion
- •References
- •Introduction
- •Modeling the Epidemic
- •Starting Point
- •Global Spread
- •Hong Kong
- •Vietnam
- •Toronto
- •Singapore, February 2003
- •China
- •Taiwan
- •Other Countries
- •Eradication
- •Outlook
- •References
- •Introduction
- •International Coordination
- •Advice to travelers
- •Management of SARS in the post-outbreak period
- •National Measures
- •Legislation
- •Extended Case Definition
- •Quarantine
- •Reduce travel between districts
- •Quarantine after Discharge
- •Infection Control in Healthcare Settings
- •General Measures
- •Protective Measures
- •Hand washing
- •Gloves
- •Face Masks
- •Additional protection
- •Getting undressed
- •Special Settings
- •Intensive Care Units
- •Intubating a SARS Patient
- •Anesthesia
- •Triage
- •Internet Sources
- •Additional information
- •Infection Control in Households
- •Possible Transmission from Animals
- •After the Outbreak
- •Conclusion
- •References
- •Case Definition
- •WHO Case Definition
- •Suspect case
- •Probable case
- •Exclusion criteria
- •Reclassification of cases
- •CDC Case Definition
- •Diagnostic Tests
- •Introduction
- •Laboratory tests
- •Molecular tests
- •Virus isolation
- •Antibody detection
- •Interpretation
- •Limitations
- •Biosafety considerations
- •Outlook
- •Table, Figures
- •References
- •Clinical Presentation and Diagnosis
- •Clinical Presentation
- •Hematological Manifestations
- •Atypical Presentation
- •Chest Radiographic Abnormalities
- •Chest Radiographs
- •CT Scans
- •Diagnosis
- •Clinical Course
- •Viral Load and Immunopathological Damage
- •Histopathology
- •Lung Biopsy
- •Postmortem Findings
- •Discharge and Follow-up
- •Psychosocial Issues
- •References
- •Appendix: Guidelines
- •WHO: Management of Severe Acute Respiratory Syndrome (SARS)
- •Management of Suspect and Probable SARS Cases
- •Definition of a SARS Contact
- •Management of Contacts of Probable SARS Cases
- •Management of Contacts of Suspect SARS Cases
- •SARS Treatment
- •Antibiotic therapy
- •Antiviral therapy
- •Ribavirin
- •Neuraminidase inhibitor
- •Protease inhibitor
- •Human interferons
- •Human immunoglobulins
- •Alternative medicine
- •Immunomodulatory therapy
- •Corticosteroids
- •Other immunomodulators
- •Assisted ventilation
- •Non-invasive ventilation
- •Invasive mechanical ventilation
- •Clinical outcomes
- •Outlook
- •Appendix 1
- •A standardized treatment protocol for adult SARS in Hong Kong
- •Appendix 2
- •A treatment regimen for SARS in Guangzhou, China
- •References
- •Pediatric SARS
- •Clinical Manifestation
- •Radiologic Features
- •Treatment
- •Clinical Course
- •References
Routes of Transmission 49
Chapter 3: Transmission
Bernd Sebastian Kamps, Christian Hoffmann
The SARS coronavirus (SARS Co-V) is predominantly spread in droplets that are shed from the respiratory secretions of infected persons. Fecal or airborne transmission seem to be less frequent.
There is growing evidence that a majority of patients might not effectively transmit the virus to other individuals: in Singapore, 162 individuals (81%) of all probable SARS cases had no evidence of transmission of a clinically identifiable illness to other persons (MMWR 52: 405-11). This is in accordance with results from epidemiological studies which indicate that SARS is moderately rather than highly transmissible (Riley).
In some instances, however, so-called "superspreader" patients are able to transmit the SARS virus to a large number of individuals. Superspreaders and nosocomial amplification were the driving factors behind the early 2003 outbreaks.
Routes of Transmission
The fact that the majority of new infections occurred in close contacts of patients, such as household members, healthcare workers, or other patients who were not protected with contact or respiratory precautions, indicates that the virus is predominantly spread by droplets or by direct and indirect contact (CDC, Seto).
The presence of virus in the stool suggests the possibility of oral-fecal transmission (Drosten, Peiris 2003b). This is reminiscent of characteristics of other coronaviruses (Cho), and feces are therefore potentially an additional route of transmission. In the Amoy Gardens outbreak (see Chapter 4: Epidemiology, Hong Kong), the SARS virus may have been spread through the sewage systems of the buildings (for details, see Government of Hong Kong Special Administrative Region).
Kamps and Hoffmann (eds.)
50 Transmission
The airborne spread of SARS does not seem to be a major route of transmission. However, the apparent ease of transmission in some instances is of concern. In particular, the cases in the original Hong Kong cluster that originated at the Metropole hotel (MMWR 52:241- 8) and in the Amoy Gardens Outbreak (Government of Hong Kong Special Administrative Region) indicate that the possibility of airborne transmission of the SARS virus, although probably a rare event, cannot be ruled out. Clusters among healthcare workers exposed during high-risk activities (i.e., endotracheal intubation, bronchoscopy, sputum induction) seem to confirm airborne transmission via a contaminated environment (i.e., re-aerosolization when removing protective equipment, etc.)
There are currently no indications that any goods, products or animals arriving from areas with SARS outbreaks pose a risk to public health. The WHO does not recommend any restrictions in this regard (http://www.who.int/csr/sars/goods2003_04_10).
Factors Influencing Transmission
Whether the transmission of a viral pathogen leads to the manifestation of the disease is determined by the intricate interplay of a multitude of still largely undefined viral and host factors.
As in other infectious diseases, the size of the inoculum, i.e., the number of infectious particles that are transmitted from one person to another, is probably of major importance. The size of the inoculum is determined by
the viral load in the secretion of the index patient, and
the distance to the index patient (face-to-face contact, crowded locations, i.e., a sneeze in the elevator)
Surprisingly, in the first few days after the onset of SARS-related symptoms, the amount of virus detected in secretion from the respiratory tract seems to be relatively low. Findings from sequential quantitative RT-PCR analyses of nasopharyngeal aspirates suggest that the viral load might peak only at around day 10 after the onset of symptoms and then decrease to the levels obtained on admission at day 15
www.SARSreference.com